Ginkgo Bioworks: Not There Yet [Seeking Alpha]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Seeking Alpha
Q3 results missed expectations, with adjusted revenues tumbling and operating losses jumping thanks to a non-recurring charge taken. DNA's working capital is at its lowest point since coverage began, and recent equity sales have led to over 13% dilution in 18 months. skynesher/E+ via Getty Images Over the last two plus years, one of the best recommendations I've made has been a sell rating on Ginkgo Bioworks ( DNA ). The cell programming and biosecurity company has seen its shares fall more This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Investors are always reminded that before making an
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene TherapyPR Newswire
- Will Ginkgo Bioworks (DNA) Leverage ARPA-H Partnership to Advance Its Oral Therapeutics Ambitions? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks: Scaling Science, Not Revenue [Seeking Alpha]Seeking Alpha
- Ginkgo Bioworks (DNA): Rethinking Valuation After New University Collaboration in ARPA-H MIGHTY Oral Health Initiative [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 11/6/25 - Miss
DNA
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 144
- 11/6/25 - Form 10-Q
- DNA's page on the SEC website